Skip to content
Search

Latest Stories

'Teach and Treat' independent prescribing pilot to be rolled out across England

Government expanding 'Teach and Treat' clinics pilot to grow the number of pharmacist independent prescribers
General practice doctor writing a prescription. (gettyimages)

The South West pilot has demonstrated it “an effective way to create Designated Prescribing Practitioner capacity and grow the number of pharmacist independent prescribers” 

Many community pharmacists are keen to pursue independent prescribing training, but the lack of access to placements, supervisors, and adequate financial support remains a challenge.

In a significant development, the government has announced the nationwide expansion of the 'Teach and Treat' clinics pilot to assist pharmacists in becoming independent prescribers (IPs).


Initially piloted in the South West, this initiative allowed many community pharmacists to gain practice-based learning, with supervision from an experienced prescriber called a Designated Prescribing Practitioner (DPP).

This expansion was confirmed in the government’s response to the House of Commons Health and Social Care Committee (HSCC) pharmacy inquiry, published on 10 January 2025.

The initiative is described as “an effective way to create designated DPP capacity and grow the number of pharmacist independent prescribers.”

The expansion of the Teach and Treat clinics will be facilitated through the Pharmacy Integration Fund in 2024-25.

While the government partially accepted the Committee’s recommendation to improve the availability and quality of necessary placements, it assured that NHS England is allocating national funding to increase the number of training places for both independent prescribers and DPPs.

“This will ensure the NHS is ready to support and mentor the trainee pharmacists from 25/26 alongside currently registered pharmacists learning to be independent prescribers (IP),” it said.

Additionally, the government’s response mentioned that the Department of Health and Social Care (DHSC) is working with NHS England to develop a single, consistent policy for funding excess travel and accommodation costs incurred by MPharm students on placements.

In a letter accompanying the response, pharmacy minister Stephen Kinnock reaffirmed the government’s commitment to “expanding the role of pharmacies and to better utilising the skills of pharmacists and pharmacy technicians.”

He stated that a refreshed Long Term Workforce Plan will be published this summer to transform health service over the next decade, ensuring timely patient care.

However, Kinnock acknowledged that there is still much more to be done, as highlighted in the Committee’s report.

NHS England is currently piloting community pharmacy prescribing across all Integrated Care Boards (ICBs), supporting a range of conditions. These pathfinders will guide future decisions regarding the service.

More For You

Community pharmacy needs investment and support to deliver neighbourhood health, says CCA chief

Community pharmacies see patients more than anyone else in the primary care system.

Getty Images

Community pharmacy key to neighbourhood health, but investment needed, says CCA chief

Community pharmacies can play a vital role in delivering a ‘neighbourhood health service’, provided they receive the necessary investment and support, according to Malcolm Harrison, chief executive of the Company Chemists’ Association (CCA).

Harrison's comments come in response to a new report from think tank Reform, titled Designing a Neighbourhood Health Service, which outlines key principles for achieving the government's vision of a more community-focused healthcare system.

Keep ReadingShow less
Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less